Nationwide’s chief market strategist Mark Hackett told CNBC’s Worldwide Exchange on Dec. 3 that survey data may look weak, but the underlying economy remains solid, creating a supportive backdrop for dip-buying and improving prospects for cyclicals and small caps. Hackett said the ongoing divide between “soft” indicators, such as consumer sentiment and PMI surveys, and […]
Roth Capital Markets initiated coverage of Microbot Medical (Microbot Medical Stock Quote, Chart, News, Analysts, Financials NASDAQ:MBOT) with a “Buy” rating and a US$5.50 price target on Dec. 3, citing the commercial rollout of the company’s LIBERTY endovascular robotic system following FDA clearance in September. Hingham, Mass.–based Microbot develops disposable robotic systems for minimally invasive […]
Share
Tweet
Share
